Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.056 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |